{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:31Z","timestamp":1787020171499,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03666-9","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:56:57Z","timestamp":1740023817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serum uric acid as a biomarker for metabolic dysfunction-associated steatotic liver disease: insights from ultrasound elastography in a Chinese cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhe","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"issue":"6","key":"3666_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (Baltimore MD). 2023;78(6):1966\u201386.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"6","key":"3666_CR2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J, et al. Global perspectives on nonalcoholic fatty liver disease and Nonalcoholic Steatohepatitis. Hepatology (Baltimore MD). 2019;69(6):2672\u201382.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"3666_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"9","key":"3666_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2468-1253(21)00132-1","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam M, Ahmed A, Despr\u00e9s JP, Jha V, Halford JCG, Wei Chieh JT, Harris DCH, Nangaku M, Colagiuri S, Targher G, et al. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases. Lancet Gastroenterol Hepatol. 2021;6(9):743\u201353.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"21","key":"3666_CR5","doi-asserted-by":"publisher","first-page":"9803","DOI":"10.1039\/D3FO03043A","volume":"14","author":"B Kong","year":"2023","unstructured":"Kong B, Liu F, Zhang S, Wu Y, Li Y, Xiong J, Tang Y, Li Y, Yao P. Associations between dietary patterns and serum uric acid concentrations in children and adolescents: a cross-sectional study. Food Funct. 2023;14(21):9803\u201314.","journal-title":"Food Funct"},{"issue":"1","key":"3666_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12937-023-00845-w","volume":"22","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Yu L, Li Y, Man Q, Jia S, Liu B, Zong W, Zhou Y, Zuo H, Zhang J. Association between dietary approaches to stop hypertension (DASH) diet and hyperuricemia among Chinese adults: findings from a nationwide representative study. Nutr J. 2023;22(1):21.","journal-title":"Nutr J"},{"issue":"13","key":"3666_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2217\/pgs-2021-0053","volume":"22","author":"W Zhang","year":"2021","unstructured":"Zhang W, Jin Y, Li J, Huang J, Chen H. Effects of genetic and nongenetic factors on hyperuricemia in Chinese patients with coronary artery disease. Pharmacogenomics. 2021;22(13):821\u201331.","journal-title":"Pharmacogenomics"},{"key":"3666_CR8","doi-asserted-by":"publisher","first-page":"1333910","DOI":"10.3389\/fpubh.2024.1333910","volume":"12","author":"K Ma","year":"2024","unstructured":"Ma K, Liu H, Guo L, Li J, Lei Y, Li X, Sun L, Yang L, Yuan T, Wang C, et al. Comparison of metabolic syndrome prevalence and characteristics using five different definitions in China: a population-based retrospective study. Front Public Health. 2024;12:1333910.","journal-title":"Front Public Health"},{"issue":"1","key":"3666_CR9","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1186\/s12889-022-14263-w","volume":"22","author":"Y Huang","year":"2022","unstructured":"Huang Y, Zhang L, Wang Z, Wang X, Chen Z, Shao L, Tian Y, Zheng C, Chen L, Zhou H, et al. The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012\u20132015. BMC Public Health. 2022;22(1):1869.","journal-title":"BMC Public Health"},{"key":"3666_CR10","doi-asserted-by":"crossref","unstructured":"Shi J, He L, Yu D, Ju L, Guo Q, Piao W, Xu X, Zhao L, Yuan X, Cao Q et al. Prevalence and Correlates of Metabolic Syndrome and Its Components in Chinese Children and Adolescents Aged 7\u201317: The China National Nutrition and Health Survey of Children and Lactating Mothers from 2016\u20132017. Nutrients 2022, 14(16).","DOI":"10.3390\/nu14163348"},{"issue":"7","key":"3666_CR11","doi-asserted-by":"publisher","first-page":"e11578","DOI":"10.1371\/journal.pone.0011578","volume":"5","author":"C Xu","year":"2010","unstructured":"Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS ONE. 2010;5(7):e11578.","journal-title":"PLoS ONE"},{"key":"3666_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, Lanaspa MA, Nakagawa T, Johnson RJ. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med. 2016;29:3\u20138.","journal-title":"Eur J Intern Med"},{"key":"3666_CR13","doi-asserted-by":"crossref","unstructured":"Zheng X, Gong L, Luo R, Chen H, Peng B, Ren W, Wang Y. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids Health Dis 2017, 16(1):202.","DOI":"10.1186\/s12944-017-0531-5"},{"issue":"5","key":"3666_CR14","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264\u2013e12811264.","journal-title":"Gastroenterology"},{"issue":"1","key":"3666_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11152\/mu-2688","volume":"23","author":"F Bende","year":"2021","unstructured":"Bende F, Sporea I, \u0218irli R, B\u00e2ldea V, Laz\u0103r A, Lupu\u0219oru R, Fofiu R, Popescu A. Ultrasound-guided attenuation parameter (UGAP) for the quantification of liver steatosis using the controlled attenuation parameter (CAP) as the reference method. Med Ultrasonography. 2021;23(1):7\u201314.","journal-title":"Med Ultrasonography"},{"issue":"7","key":"3666_CR16","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep4.1935","volume":"6","author":"M Noureddin","year":"2022","unstructured":"Noureddin M, Ntanios F, Malhotra D, Hoover K, Emir B, McLeod E, Alkhouri N. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017\u20132018 transient elastography data and application of machine learning. Hepatol Commun. 2022;6(7):1537\u201348.","journal-title":"Hepatol Commun"},{"issue":"6","key":"3666_CR17","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"1","key":"3666_CR18","doi-asserted-by":"publisher","first-page":"e23429","DOI":"10.1016\/j.heliyon.2023.e23429","volume":"10","author":"E Zhao","year":"2024","unstructured":"Zhao E, Wen X, Qiu W, Zhang C. Association between body roundness index and risk of ultrasound-defined non-alcoholic fatty liver disease. Heliyon. 2024;10(1):e23429.","journal-title":"Heliyon"},{"issue":"6","key":"3666_CR19","doi-asserted-by":"publisher","first-page":"e0252164","DOI":"10.1371\/journal.pone.0252164","volume":"16","author":"X Zhang","year":"2021","unstructured":"Zhang X, Heredia NI, Balakrishnan M, Thrift AP. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: results from NHANES 2017\u20132018. PLoS ONE. 2021;16(6):e0252164.","journal-title":"PLoS ONE"},{"key":"3666_CR20","doi-asserted-by":"crossref","unstructured":"Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L\u00e9dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 2017;66(5):1022\u201330.","DOI":"10.1016\/j.jhep.2016.12.022"},{"issue":"3","key":"3666_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","volume":"62","author":"JC Sirota","year":"2013","unstructured":"Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metab Clin Exp. 2013;62(3):392\u20139.","journal-title":"Metab Clin Exp"},{"issue":"11","key":"3666_CR22","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1515\/cclm-2023-0177","volume":"61","author":"A \u00c5sberg","year":"2023","unstructured":"\u00c5sberg A, L\u00f8fblad L, Hov GG. The likelihood ratios of FIB-4-values for diagnosing advanced liver fibrosis in patients with NAFLD. Clin Chem Lab Med. 2023;61(11):e233\u20134.","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"3666_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/17474124.2018.1463158","volume":"12","author":"Y Peng","year":"2018","unstructured":"Peng Y, Li Y, He Y, Wei Q, Xie Q, Zhang L, Xia Y, Zhou X, Zhang L, Feng X, et al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. Expert Rev Gastroenterol Hepatol. 2018;12(5):503\u201313.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"3666_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5152\/tjg.2022.20715","volume":"33","author":"J WenYi","year":"2022","unstructured":"WenYi J, Ting Q, PiaoPiao Y, JinMing W. Association between Neutrophil-to-lymphocyte ratio with inflammatory activity and fibrosis in non-alcoholic fatty liver disease. Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol. 2022;33(1):53\u201361.","journal-title":"Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol"},{"key":"3666_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/CLEP.S403314","volume":"15","author":"Q Sun","year":"2023","unstructured":"Sun Q, Zhang T, Manji L, Liu Y, Chang Q, Zhao Y, Ding Y, Xia Y. Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and Meta-analysis. Clin Epidemiol. 2023;15:683\u201393.","journal-title":"Clin Epidemiol"},{"issue":"8","key":"3666_CR26","doi-asserted-by":"publisher","first-page":"e3497","DOI":"10.1210\/clinem\/dgac190","volume":"107","author":"S Li","year":"2022","unstructured":"Li S, Fu Y, Liu Y, Zhang X, Li H, Tian L, Zhuo L, Liu M, Cui J. Serum uric acid levels and nonalcoholic fatty liver disease: a 2-Sample bidirectional mendelian randomization study. J Clin Endocrinol Metab. 2022;107(8):e3497\u2013503.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3666_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12876-021-01615-w","volume":"21","author":"M Zhou","year":"2021","unstructured":"Zhou M, Yang N, Xing X, Chang D, Li J, Deng J, Chen Y, Hu C, Zhang R, Lu X, et al. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. BMC Gastroenterol. 2021;21(1):43.","journal-title":"BMC Gastroenterol"},{"key":"3666_CR28","doi-asserted-by":"crossref","unstructured":"Yen PC, Chou YT, Li CH, Sun ZJ, Wu CH, Chang YF, Lu FH, Yang YC, Chang CJ, Wu JS. Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It. Journal of clinical medicine 2022, 11(5).","DOI":"10.3390\/jcm11051445"},{"key":"3666_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2021.11.034","volume":"178","author":"W Yu","year":"2022","unstructured":"Yu W, Chen C, Zhuang W, Wang W, Liu W, Zhao H, Lv J, Xie D, Wang Q, He F, et al. Silencing TXNIP ameliorates high uric acid-induced insulin resistance via the IRS2\/AKT and Nrf2\/HO-1 pathways in macrophages. Free Radic Biol Med. 2022;178:42\u201353.","journal-title":"Free Radic Biol Med"},{"key":"3666_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fendo.2018.00098","volume":"9","author":"EJ Tassone","year":"2018","unstructured":"Tassone EJ, Cimellaro A, Perticone M, Hribal ML, Sciacqua A, Andreozzi F, Sesti G, Perticone F. Uric acid impairs insulin signaling by promoting Enpp1 binding to insulin receptor in human umbilical vein endothelial cells. Front Endocrinol. 2018;9:98.","journal-title":"Front Endocrinol"},{"key":"3666_CR31","doi-asserted-by":"publisher","first-page":"821689","DOI":"10.3389\/fendo.2022.821689","volume":"13","author":"C Yang","year":"2022","unstructured":"Yang C, He Q, Chen Z, Qin JJ, Lei F, Liu YM, Liu W, Chen MM, Sun T, Zhu Q, et al. A bidirectional relationship between Hyperuricemia and Metabolic Dysfunction-Associated fatty liver disease. Front Endocrinol. 2022;13:821689.","journal-title":"Front Endocrinol"},{"issue":"6","key":"3666_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","volume":"37","author":"R Spiga","year":"2017","unstructured":"Spiga R, Marini MA, Mancuso E, Di Fatta C, Fuoco A, Perticone F, Andreozzi F, Mannino GC, Sesti G. Uric acid is Associated with inflammatory biomarkers and induces inflammation Via activating the NF-\u03baB signaling pathway in HepG2 cells. Arterioscler Thromb Vasc Biol. 2017;37(6):1241\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3666_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/ijms17040548","volume":"17","author":"R Lombardi","year":"2016","unstructured":"Lombardi R, Pisano G, Fargion S. Role of serum uric acid and ferritin in the Development and Progression of NAFLD. Int J Mol Sci. 2016;17(4):548.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3666_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269\u201375.","journal-title":"J Hypertens"},{"key":"3666_CR35","doi-asserted-by":"crossref","unstructured":"Hong T, Chen Y, Li X, Lu Y. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxidative medicine and cellular longevity 2021;2021:6889533.","DOI":"10.1155\/2021\/6889533"},{"issue":"3","key":"3666_CR36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","volume":"160","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on Lifestyle Modification using Diet and Exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: Expert Review. Gastroenterology. 2021;160(3):912\u20138.","journal-title":"Gastroenterology"},{"issue":"2","key":"3666_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jhep.2021.10.023","volume":"76","author":"D Kim","year":"2022","unstructured":"Kim D, Ahmed A. Reply to: NAFLD vs. MAFLD - it is not the name but the disease that decides the outcome in fatty liver. J Hepatol. 2022;76(2):477\u20138.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03666-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03666-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03666-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:43:06Z","timestamp":1740066186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03666-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03666-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving research study participants were approved by the Ethics Committee of Xi\u2019an Fengcheng Hospital (approval number: 2024-001-01). The requirement for informed consent was waived by the Ethics Committee of Xi\u2019an Fengcheng Hospital due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Registration date"}}],"article-number":"94"}}